EXEL vs NTRS · P/E 17, rev $628.7M vs P/E 18, rev $2.69B
Exelixis Inc (EXEL) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the EXEL and NTRS stock pages for the full models.
Not investment advice.